October 23, 2011
Seattle, WA and Rockville, MD (October 24, 2011):–Mammography Reporting System, the most widely used tracking & reporting system in the world for all breast-related procedures, including mammography, MRI, and ultrasound, announced it has partnered with DrFirst to provide comprehensive e-prescribing and medication management functionality with the MRS7 Reporting software as a part of the MRS initiative to achieve Meaningful Use certification as an ambulatory EMR. The partnership brings the safety and efficiency benefits of DrFirst’s Gold Certified Rcopia e-prescribing to MRS7 Reporting software.
“Partnering with DrFirst in this integration extends the capabilities of thousands of MRS users to achieve early compliance with the Meaningful Use guidelines established by HHS,” said MRS President Mark P. Morris. “Although radiologists have been investing heavily in IT for years, significant financial incentives from the government will help them remain on the leading edge of new IT capabilities. E-prescribing is a Meaningful Use requirement, and we are happy to be able to offer DrFirst’s best-of-breed solution.”
“As indicated in our name, DrFirst’s goal is always to put the doctor first. Integrating with MRS is a wonderful example of a partner sharing our vision,” said DrFirst President G. Cameron Deemer. “The announcement of the DrFirst-MRS partnership is especially timely with October being National Breast Cancer Awareness Month. This integration will allow MRS clients and their patients to benefit from enhanced patient safety realized when e-prescribing, to participate in current government incentive programs including ARRA/HITECH, PQRI and MIPPA, and to avoid future reductions in reimbursement.”
With the integration of DrFirst’s Rcopia e-prescribing technology, MRS users will be able to easily and securely submit electronic prescriptions to any retail or mail-order pharmacy while accessing comprehensive clinical information for each patient. Accessible patient information includes drug and allergy interactions, complete prescribing histories and formulary information. Doctors and staff will be able to easily access the Surescripts-certified functionality from within the MRS system and all resulting prescribing data is instantly captured within the application.
About Mammography Reporting System (MRS)
Mammography Reporting System (MRS) is the most widely used tracking & reporting system in the world for all breast-related procedures. MRS is installed worldwide in thousands of facilities, from IDN’s with over 50 hospitals and clinics, to small imaging facilities with one or two radiologists. The MRS system tracks breast procedure patients, collects their data, and generates reports and patient lay letters while providing breast cancer risk calculations to individualize breast health management strategies for all women by their medical caregivers. By year end 2011 MRS will achieve full ambulatory EHR certification. MRS is based on the fundamental idea that information is paramount in the eyes of both the clinician and the patient. For more information, visit www.mrsys.com or call 800-253-4827.